Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Jalid Sehouli, Sébastien Armanet, NP137, Thomas Herzog and the tag gyn.
Shares A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors, Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments, Jalid Sehouli, Sébastien Armanet and the tag gyn.
Shares Nykode Therapeutics, A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer, Inovio Pharmaceuticals, A Study of IDP-001 in Advanced or Metastatic Solid Tumors.
Shares Aga Khan University Hospital, Nairobi, A Study of IDP-001 in Advanced or Metastatic Solid Tumors, CLIP1, Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors.
Shares Stop over-excluding people who could become pregnant; study pregnancy exposure, Nurse-led chemotherapy day units with a doctor on a screen, TUBA1A, TUBA1B.
Shares André Ilbawi, Mobile diagnostic units that biopsy, scan and treat on the same visit, Hologic, Philippine General Hospital.
Shares EIF3E, Pyrexar Medical, CDC National Breast and Cervical Cancer Early Detection Program, SND1.
Shares Low-cost cobalt-60 brachytherapy for cervical cancer in every regional centre, Community health workers trained in cancer triage, navigation and home palliative care, HPV self-testing with same-day treatment as the national cervical programme, Validate low-cost metronomic oral regimens in phase 3 and carry them into guidelines.
The same record for scripts and assistants; checked 2026-09-07. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.